ArticleBMC medical imaging2026
Construction of a prognostic model for colorectal cancer based on clinical parameters and quantitative body composition using CT imaging.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesIn colorectal cancer (CRC) patients, body composition (BC) has been recognized as a patient-specific imaging biomarker associated with prognosis. This study aims to construct a joint prediction model based on computed tomography (CT) quantitative body composition and clinical parameters using the Least Absolute Shrinkage and Selection Operator (LASSO) regression model and evaluate its prognostic value in patients undergoing curative surgery for CRC. MATERIALS AND
methodsThis multicenter retrospective study analyzed 377 CRC patients who underwent surgical resection from 2017 to 2022. The cohort was split into a training set and a validation set. CT images at the L3 and umbilical levels within 3 months pre-surgery were used to quantify body composition. LASSO regression and COX proportional hazard regression identified independent prognostic factors and developed nomogram prediction models. Model performance was assessed using C-index, receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis (DCA), and external validation.
resultsLASSO regression identified 7 clinical indicators strongly associated with OS and DFS, respectively. Nomogram prediction models were then created incorporating body composition indicators. ROC curves showed the area under the curve (AUC) of 0.915 and 0.882 for 5 years OS and DFS, respectively. The combined model significantly outperformed TNM staging alone, with AUCs of 0.915 vs. 0.788 for 5 years OS in the training set, and 0.910 vs. 0.735 in the validation set. Calibration and DCA curves indicated strong predictive ability and clinical effectiveness.
conclusionThe combined prediction model based on CT-quantified body composition and clinical indicators effectively predicts CRC prognosis, outperforming the single TNM stage model. CLINICAL TRIAL NUMBER: Retrospective study, not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.